Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAVITY trial of rosuvastatin + ezetimibe versus simvastatin + ezetimibe in high-risk hypercholesterolaemia
2007-002810-20Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rosuvastatin, ezetimibe and simvastatin in hypercholesterolemia and dyslipidemia (4 arms), sponsored by AstraZeneca. Primary endpoints: Percent change in LDL-C, LDL-C lowering efficacy and 1 more. Started Jul 2007; status: completed.
02
Drugs
rosuvastatinezetimibesimvastatin
03
Conditions
hypercholesterolemiadyslipidemia
Beyond the preview
Go deeper on 2007-002810-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002810-20.